SCHEMBL27280756

SCHEMBL27280756

CNCC1(O)CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3517313 0.97 SLC6A4 (0.41)
Hydrochloric Acid SCHEMBL4811567 0.95 SLC6A4 (0.39)
SCHEMBL14043771 0.94
SCHEMBL9966034 0.88
Hydrochloric Acid SCHEMBL15511667 0.86
SCHEMBL16373529 0.80 KDM4E (0.33)
SCHEMBL17780232 0.77 KDM4E (0.38)
SCHEMBL15001306 0.77
SCHEMBL9173934 0.75 SOS1 (0.31)
Hydrochloric Acid SCHEMBL9177661 0.75 KDM4E (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250388568-A1 NLRP3 INHIBITORS KODIAK SCIENCES INC (US) 2025-12-25 US disclosed
EP-4551549-A1 NLRP3 INHIBITORS Kodiak Sciences Inc. (US) 2025-05-14 EP disclosed
WO-2024081311-A1 CBL-B MODULATORS AND USES THEREOF NIMBUS CLIO, INC. (US) 2024-04-18 WO disclosed
WO-2024010772-A1 NLRP3 INHIBITORS KODIAK SCIENCES INC. (US) 2024-01-11 WO disclosed